career start bw’s Post

Karolinska University Hospital Ranks 3rd Among Europe's Most Innovative Research Hospitals⭐ Karolinska Universitetssjukhuset has been recognized as the third most innovative research hospital in Europe, according to the European Patent Office's latest Academic Patents 2025 report. The hospital filed 479 academic patents between 2001 and 2020, ranking only after Paris University Hospitals (AP-HP) and Copenhagen University Hospital. This achievement reflects the strong synergy between healthcare delivery, research, and innovation at the institution. 👉 Read the full news article in Swedish: https://lnkd.in/gf9F7DC7 👉 Learn more about Stockholm's life science ecosystem and innovation landscape: https://lnkd.in/dxSFKHFP #LifeScience #MedicalInnovation #Healthcare #Research #Stockholm #Innovation #Karolinska

2️⃣ of the 7️⃣ hospitals with the most patent applications in Europe are located in THE LÄND! It's no secret that the German Southwest is a hub for medical technology. However, a recent study by the European Patent Office highlights the region's outstanding medical research capabilities once again. Between 2001 and 2020, the University Hospitals of Heidelberg and Freiburg were significantly involved in the 2,858 European patents filed in Germany. This extraordinary concentration of expertise is supported by a dynamic ecosystem. Universities, Fraunhofer Institutes, research hospitals, and industry partners collaborate closely to transform ideas into market-ready solutions. For international companies, this means direct access to cutting-edge technologies, cooperative networks, and a highly qualified talent pool. Become part of the ecosystem and discover your potential in THE LÄND. Don’t just expand – EXPÄND INTO THE LÄND. We are committed to help you succeed. 🔗Visit: https://bit.ly/47lGjKU

🚀 Kick-off of the Austrian Core Facilities Network at BOKU University! On September 24, 2025, BOKU University hosted the kick-off meeting of the Austrian Core Facilities Network. Representatives from universities and research institutions across Austria - including University of Natural Resources and Life Sciences, Vienna (BOKU), Medical University of Vienna, Medizinische Universität Graz, Medizinische Universität Innsbruck, Universität Wien, Universität Innsbruck , Johannes Kepler Universität Linz , Universität Salzburg , Technische Universität Wien, Vetmeduni, and Bundesministerium für Frauen, Wissenschaft und Forschung - came together to launch this collaborative initiative. The meeting focused on: ✅ Strengthening collaboration across Core Facilities ✅ Consolidating expertise and addressing shared challenges ✅ Promoting regular exchange through meetings and working groups The initiative represents the first step toward a coordinated, sustainable, and state-of-the-art Core Facilities landscape, providing researchers with access to advanced technologies and expertise. #BOKUCoreFacilities #ResearchInfrastructure #ScienceCollaboration #CoreFacilities

💡 𝐏𝐮𝐛𝐥𝐢𝐜 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡: 𝐅𝐫𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐆𝐞𝐫𝐦𝐚𝐧𝐲 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞 𝐢𝐧 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐩𝐚𝐭𝐞𝐧𝐭 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 As the 2025 Nobel Prize in Economics goes to Philippe Aghion, who calls for a Europe capable of strengthening its technological leadership, the latest study from the European Patent Office (EPO) feels particularly relevant. At Barabino & Partners International, we are proud to support the EPO’s media relations for this campaign in Germany and France, highlighting the essential contribution of public research to Europe’s innovation landscape. 𝐀𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲: Conducted with Fraunhofer Institute for Systems and Innovation Research ISI, this report analyses for the first time the role of public research organisations, university hospitals, and research-based start-ups in driving innovation across Europe. It confirms France’s leading role in shaping a Europe of knowledge and innovation, where public research fuels the technologies of the future: health, biotechnology, semiconductors, and digital technology. Read more : The role of European public research in patenting and innovation 🇫🇷 𝐈𝐧 𝐅𝐫𝐚𝐧𝐜𝐞 Public research drives nearly 40% of all European patents filed by public institutions. Leaders such as CNRS, Commissariat a l'Energie Atomique et aux Energies Alternatives, and INSERM stand out, alongside university hospitals like Greater Paris University Hospitals - AP-HP and more than 550 research spin-offs showcasing France’s vitality in health, biotech, semiconductors, and digital innovation. 🇩🇪 𝐈𝐧 𝐆𝐞𝐫𝐦𝐚𝐧𝐲 Ranked second after France, universities, start-ups, and research hospitals are also among Europe’s most active patent filers — including University Hospital Heidelberg (UKHD), Charité - Universitätsmedizin Berlin, and Universitätsklinikum Freiburg, supported by the Fraunhofer Institute for Systems and Innovation Research ISI and Max Planck Institute. This dynamic reflects a Europe of knowledge and innovation, where public research fuels not only technological progress, but also entrepreneurship and regional development. Discover our key media coverage in the comments below ⬇️ Le Figaro explores how France’s public research vitality fuels start-up creation and entrepreneurship ZDF Heute reports how Germany’s universities, start-ups, and research hospitals are among Europe’s leaders in patent activity #Patents #research #EU #Europe #Communications #mediarelations

Europe is home to world-class universities, pioneering research institutions, and a tradition of scientific excellence that has driven medical breakthroughs for centuries. These assets give Europe the opportunity to build a globally competitive life sciences ecosystem, but only if the right choices are made now. Now, #EuropesChoice is whether to build on its strengths, invest in innovation and create the right environment for medicine development and production, or stand on the sidelines and watch other regions reap the benefits. Read more: https://lnkd.in/dSj5J2Mk #WeWontRest

EFPIA makes a compelling case: Europe has the fundamental building blocks - world-class universities, pioneering research institutions, and a rich tradition of scientific excellence. The question is whether we'll capitalize on these strengths or let them slip away to more competitive regions. From a health economics perspective, this isn't just about preserving legacy - it's about securing Europe's future as a global leader in medicine development and production. The window for decisive action is narrowing.

💡 #FundingFriday opportunity The British Academy, in partnership with the Royal Society, Academy of Medical Sciences, and Royal Academy of Engineering, is offering Pump Priming collaboration grants to strengthen UK–EU research partnerships under Horizon Europe. These grants aim to kick-start collaborations and help researchers make the most of the UK’s association with Horizon Europe. 🔬 Open to all disciplines — including engineering, natural sciences, medical and health sciences, humanities, and social sciences. 💰 Funding available: Up to £10,000 🗓️ Deadline: Weds 5 November 2025, 17:00 (GMT) 👉 Learn more: https://buff.ly/O48hLNE #FundingFriday #ResearchCollaboration #HorizonEurope #UKResearch #InternationalPartnerships #FundingOpportunity

According to a recent report by the European Patent Office (EPO) and Fraunhofer Institute for Systems and Innovation Research ISI, Dutch public research institutions are among Europe’s most active innovators. Between 2001 and 2020, they filed over 8,300 international patent applications, confirming the Netherlands’ strong position in translating scientific discoveries into practice. TNO stands out as one of the top contributors, reflecting its central role in driving applied research and technological development. TNO’s work demonstrates how close collaboration between science and industry fuels impactful innovation. Leiden University Medical Center (LUMC) is also highlighted as a leader in direct patent submissions, a clear indication that the translation from medical science to market is exceptionally well-organised. At Leiden Bio Science Park, this connection between fundamental science and application is part of our daily reality. The collaboration between universities, research institutes, and companies creates a fertile ground where ideas grow into solutions that improve health and quality of life. These results reaffirm the importance of strong connections between research, technology transfer, and entrepreneurship, connections that continue to strengthen within our community.

We need more start ups in Europe! Last week the European Patent Office Observatory presented in an online event a new study around the first mapping of European hospitals and public research patenting activities. The snippit in this post is a contribution of mine to the discussion. You maybe identify my passion about bringing more venture capital into the European and especially the German market. Our society needs on a macroeconomic level a much broader pipeline of start-up companies in order to create more value out of the excellent science we have at our universities and public research organizations. I want to sincerely thank my panelist colleagues for the high quality discussion Mehdi GMAR from CNRS, Muriel Attané from EARTO - European Association of Research and Technology Organisations, Noa Bach from Greater Paris University Hospitals - AP-HP, and our moderator Víctor Arribas Martínez from European Patent Office #innovation #patents #research #science # scienceapplication ➡️ Find more information in the links Watch the full debate: https://lnkd.in/d2eRrjuN The Press Release of the Max-Planck-Society: https://lnkd.in/eMNf2WmM Link to the full report of the EPO: https://lnkd.in/dXK_bdvb

“Our society needs a much broader pipeline of start-up companies in order to create more value out of the excellent science we have at our universities and public research organizations.” – Christoph Hüls, PhD, Managing Director, Max-Planck-Innovation GmbH This quote emerged during the launch event of the European Patent Office (EPO)’s first Europe-wide study on the role of public research organizations in patenting and innovation. Experts from policy, research, and industry came together to discuss how public research drives Europe’s competitiveness and how we can translate scientific excellence into innovation and impact. At our start-up incubator MAX!mize – a dedicated program by Max-Planck-Innovation GmbH – we’re exactly here for that: We support outstanding research teams in turning scientific breakthroughs into scalable start-ups. By bridging the gap between lab and market, we aim to strengthen Europe’s innovation ecosystem and turn knowledge into impact. 💡 🚀 Are you ready to bring your Max Planck research to market and explore the world of entrepreneurship? ➡️ Apply now for the next round of our MAX!mize incubator: https://lnkd.in/eH5Fy5UV #Innovation #Startups #Entrepreneurship #MaxPlanck #TechnologyTransfer